Stabilized pharmaceutical admixture composition

Patent 5015481 Issued on May 14, 1991. Estimated Expiration Date:

May 3, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Abstract Claims Description Full Text

Patent References

3903297

Restoration of interferon response
Patent #: 4092425
Issued on: 05/30/1978
Inventor: Stringfellow

Stabilized oral prostaglandin formulation and the process for the preparation thereof
Patent #: 4113882
Issued on: 09/12/1978
Inventor: Okazaki , et al.

Stabilization of 16-oxygenated prostanoic acid derivatives
Patent #: 4301146
Issued on: 11/17/1981
Inventor: Sanvordeker

Antidiarrheal compositions and use thereof
Patent #: 4666716
Issued on: 05/19/1987
Inventor: Sheth , et al.

Sustained release dosage form based on highly plasticized cellulose ether gels
Patent #: 4678516
Issued on: 07/07/1987
Inventor: Alderman , et al.

Sustained release dosage form based on highly plasticized cellulose ether gels
Patent #: 4695464
Issued on: 09/22/1987
Inventor: Alderman

Orally administerable sustained release pharmaceutical formulations
Patent #: 4797286
Issued on: 01/10/1989
Inventor: Thakkar , et al.

Orally administerable sustained release pharmaceutical formulations
Patent #: 4847092
Issued on: 07/11/1989
Inventor: Thakkar , et al.

Antidiarrheal compositions and use thereof
Patent #: 4867979
Issued on: 09/19/1989
Inventor: Sheth , et al.

More ...

Inventors

Application

No. 518354 filed on 05/03/1990

US Classes:

424/494, Cellulose derivatives514/781, Cellulose or derivative514/970CONTAINING DESIGNATED INGREDIENT TO STABILIZE AN ACTIVE INGREDIENT

Examiners

Primary: Rose, Shep K.

Attorney, Agent or Firm

Matukaitis; Paul D., Williams; Roger A.

Foreign Patent References

8656761 AU. 10/13/1987

International Classes

A61K 009/00
A61K 045/08

Abstract

A stabilized pharmaceutical composition which is an admixture of an NSAID selected from diclofenac and piroxicam, a prostaglandin and hydroxypropyl methylcellulose for maintaining the prostaglandin in a therapeutically effective amount without negatively affecting the therapeutic activity of the NSAID.

Other References

James et al., Hyperalgesia after Treatment of Mice with etc., Arzneimittelforschung, 28, 804-7, 01/78
Mikami et al., The Potentiating Effects of Prostaglandins on etc., J. Pharm. Pharmacol., 31, 856-7, 01/79
Walter et al., Effects of Analgesics on Bradykin-Induced etc., Agents and Actions, 27, 375-7, 01/79
Taiwo et al., Prostaglandins Inhibit Endogenous Pain Control etc., J. Neurosci., 8, 1346-9, 01/88
Pateromichelakis et al., Prostaglandin E1-Induced Sensitization of Aa etc., Brain Research, 232, 89-96, 01/82
Sanyal et al., Prostaglandins: Antinociceptive Effect of etc., Clin. Exp. Pharmacol. Physiol., 4, 247-55, 01/77
Bhattacharya et al., Potentiation of Antinociceptive Action of etc., Clin. Exp. Pharmacol. Physiol., 2, 353-357, 01/75
Ferri et al., Decreased Antinociceptive Effect of Morphine etc., Psychopharmacologia, 39, 231-5, 01/74
Sanyal et al., The Antinociceptive Effect of etc., Psychopharmacology, 60, 159-63, 01/79
G. D. Searle & Co., Cytotec (Misoprostol) Drug Information, Physician's Desk Reference, 44, 2056-7, 01/90
IMS, IMS Marketletter, IMS Marketletter, 06/87
Myamoto et al., CA-106:182704v (1987)
Shah et al., CA-107:141114e (1987)
Euro-Celtique CA-107:161685y (1987)
Mizukami CA-107:223298g (1987)
Mizukami et al., CA-110:63743e (1988)
Vyas et al., CA-112:42452k (1989)
Okada et al., CA-113:65269r (1990)
Igura et al., CA-110:219072y (1988